Catalyst Wire Dossier Catalyst Wire Dossier

CD19-specific T-cell therapy

· MD Anderson Cancer Center
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CD19-specific T-cell therapy, covering 2017-08-17 to 2017-08-17. Get the full timeline:

Most recent: Clinical Trial Update: CD19-specific T-cell for Chronic Lymphocytic Leukemia (CLL) [Phase 1]

See pricing